As a Free StocksGuide user, you can view scores for all 7,079 stocks worldwide.
25 Analysts have issued a Zealand Pharma forecast:
25 Analysts have issued a Zealand Pharma forecast:
| Sep '25 |
+/-
%
|
||
| Revenue | 9,155 9,155 |
11,810%
11,810%
|
|
| Gross Profit | 9,154 9,154 |
16,426%
16,426%
|
|
| EBITDA | 7,293 7,293 |
774%
774%
|
|
| EBIT (Operating Income) EBIT | 7,267 7,267 |
745%
745%
|
|
| Net Profit | 6,543 6,543 |
722%
722%
|
|
In millions DKK.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Zealand Pharma A/S is a biotechnology company, which engages in the discovery, design, and development of peptide based medicines. Its products include Zegalogue and V-Go. The company was founded by Lars Hellerung Christiansen and Bjarne Due Larsen on April 1, 1997 and is headquartered in Soborg, Denmark.
| Head office | Denmark |
| CEO | Adam Steensberg |
| Employees | 335 |
| Founded | 1997 |
| Website | www.zealandpharma.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


